Image via Wikipedia
Human embryonic stem cells implanted into mice specifically engineered to have a serious retinal dysfunction resulting in blindness have restored the animal’s capacity to sense light during tests.
The results, published in international magazine, Cell Stem Cell, were obtained in the United States by a research group in the Department of Biological Structure at the University of Washington in Seattle. The study, performed by Deepak Lamba, Juliane Gust, and Thomas Reh, demonstrated that it is possible to obtain retina progenitor cells from stem cells derived from the embryo. The researchers observed, “In principle, embryonic stem
Cardinal Gianfranco Ravasi (image by Getty Images via @daylife)
An international conference entitled: ‘Adult Stem Cells: Science and the Future of Man and Culture‘ is due to begin today in the Vatican, lasting until 11 November. The event, which has been organised by the US Stem for Life Foundation and by the Pontifical Council for Culture, has the aim of supporting research and increasing public awareness of treatment using adult stem cells.
The conference will be attended by 350 scientists, religious figures, politicians, educators and industry representatives.
Primary stem cells are of two kinds: embryonic and adult. When a stem cell
Image by Jessica DeWinter via Flickr
“Stem cells are no longer only the future of aesthetic surgery, they are the present,” said Alessandro Gennai, an associate plastic surgeon at the European Academy of Facial Plastic Surgery (EAFPS). For the past year, Gennai has been using a modified technique used to preserve stem cells in lipofilling procedures. “I have already performed numerous operations, with excellent results and without side-effects,” said the surgeon from Bologna, “therefore I can say that lipofilling is the best solution for someone who wants to eliminate wrinkles before the summer. The procedure lasts 30
Pluristem Therapeutics Inc. today announced that it has begun enrolling patients in the U.S. for a Phase I clinical trial with its unmatched placenta-derived stem cell product, PLX-PAD, the Company`s leading product candidate for the treatment of critical limb ischemia (CLI), the end-stage of peripheral artery disease (PAD).
Enrollment began at the Center for Therapeutic Angiogenesis in Birmingham, Ala., one of two clinical sites in the U.S. Duke University Medical Center will also be screening patients for the trial. The initiation of this study follows the approval of the Company`s Investigational New Drug (IND) application to begin clinical trials with
Image via Wikipedia
FREMONT, CA – The first human trials involving stem cell therapy were approved just weeks ago, but a growing number of other patients are already benefitting from stem cell treatments. Those patients are dogs and the results are reportedly encouraging.
Cris the police dog is a five-year-old German Shepherd who was a whisker away from retirement last year when he tore a muscle in his rear leg during training. “He was jumping and the next morning he came and he wouldn’t put any weight on his leg at all,” Fremont Police Officer Matt Snelson said.
Snelson is Cris’ partner